"The Report EpiCast
Report: Type 2 Diabetes - Epidemiology Forecast to 2025 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
Type
2 diabetes (T2D),
formerly known as non-insulin dependent diabetes mellitus or
adult-onset diabetes mellitus, is a chronic disorder of glucose
equilibrium that results from the bodys inability to make use of
available insulin along with relative insulin deficiency. T2D
constitutes approximately 90% of all diabetes cases around the world;
type 1 diabetes (T1D) and gestational diabetes make up the remaining
10% of the cases. Risk factors for T2D are broadly categorized as
either modifiable or non-modifiable risk factors. Lifestyle factors
such as obesity, physical inactivity, and dietary habits are
modifiable risk factors, whereas family history and advancing age are
non-modifiable risk factors. T2D is also associated with several
comorbidities, such as CKD, CVD, hypertension, and dyslipidemia,
which can worsen the quality of life of the patient, and can lead to
poor therapeutic outcomes. Diabetes is one of the most common
non-communicable diseases worldwide and is an escalating public
health problem globally.
GlobalData
epidemiologists forecast an increase in the diagnosed prevalent cases
of T2D in the 9MM, from 116,871,808 diagnosed prevalent cases in 2015
to 151,907,657 diagnosed prevalent cases in 2025, with an Annual
Growth Rate (AGR) of 3.00%. The projected increase in the diagnosed
prevalent cases of T2D across all the markets covered in this
analysis is attributed to the actual increase in the incidence of T2D
along with the change in population demographics in the respective
markets.
GlobalData
epidemiologists utilized country-specific diagnosed prevalence data
for T2D across the 9MM. Additionally, the epidemiological forecast
for the diagnosed prevalent cases of T2D in the 9MM is supported by
nationally representative longitudinal historical data obtained from
studies in respective countries published in peer-reviewed journals
or national healthcare databases, which provide a detailed insight
into the epidemiology of the disease in these markets.
Scope
-
The Type 2 Diabetes (T2D) EpiCast Report provides an overview of the
risk factors and global trends of T2D in the 9MM (US, France,
Germany, Italy, Spain, UK, Japan, China, and India). It includes a
10-year epidemiology forecast of T2D diagnosed prevalent cases
segmented by age (in ten-year increments beginning at ages 20-30
years and ending at age 80 years and older), sex, and comorbidities
including chronic kidney disease (CKD), cardiovascular disease (CVD),
overweight/obesity, hypertension, and dyslipidemia in these nine
markets.
-
The T2D epidemiology report is written and developed by Masters- and
PhD-level epidemiologists.
-
The EpiCast Report is in-depth, high quality, transparent and
market-driven, providing expert analysis of disease trends in the
9MM.
Reasons to buy
The
T2D EpiCast report will allow you to -
-
Develop business strategies by understanding the trends shaping and
driving the global T2D market.
-
Quantify patient populations in the global T2D market to improve
product design, pricing, and launch plans.
-
Organize sales and marketing efforts by identifying the age groups
and sex that present the best opportunities for T2D therapeutics in
each of the markets covered.
-
Identify the percentage of T2D diagnosed prevalent cases by age, sex,
and comorbidities.
Table
of Contents
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 8
2.3 Upcoming Related Reports 9
3 Epidemiology 10
3.1 Disease Background 10
3.2 Risk Factors and
Comorbidities 11
3.3 Global Trends 12
3.3.1 US 12
3.3.2 5EU 13
3.3.3 Japan 13
3.3.4 China and India 14
3.4 Forecast Methodology 14
3.4.1 Sources Used for
Diagnosed Prevalence of T2D 19
3.4.2 Sources Not Used 30
3.4.3 Forecast Assumptions and
Methods, Diagnosed Prevalent Cases of T2D 31
3.5 Epidemiological Forecast
for T2D (2015-2025) 42
3.5.1 Diagnosed Prevalent Cases
of T2D 42
3.5.2 Age-Specific Diagnosed
Prevalent Cases of T2D 44
3.5.3 Sex-Specific Diagnosed
Prevalent Cases of T2D 46
3.5.4 Age-Standardized
Diagnosed Prevalence of T2D 48
3.5.5 Prevalent Cases of
Chronic Kidney Disease Among Diagnosed T2D Cases 49
3.5.6 Prevalent Cases of
Cardiovascular Disease Among Diagnosed T2D Cases 50
3.5.7 Prevalent Cases of
Overweight/Obesity Among Diagnosed T2D Cases 51
3.5.8 Prevalent Cases of
Hypertension Among Diagnosed T2D Cases 52
3.5.9 Prevalent Cases of
Dyslipidemia Among Diagnosed T2D Cases 53
3.6 Discussion 54
3.6.1 Epidemiological Forecast
Insight 54
3.6.2 Limitations of the
Analysis 55
3.6.3 Strengths of the Analysis
55
4 Appendix 57
4.1 Bibliography 57
4.2 About the Authors 64
4.2.1 Epidemiologists 64
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment